| 7th Jun 2021 7:00 am |
RNS |
Destiny Pharma welcomes G7’s Communique on AMR |
| 3rd Jun 2021 12:03 pm |
RNS |
Result of AGM |
| 2nd Jun 2021 7:00 am |
RNS |
Positive update on microbiome therapeutic NTCD-M3 |
| 25th May 2021 7:00 am |
RNS |
Further information re AGM |
| 19th May 2021 7:00 am |
RNS |
Notice to Register for 2021 AGM |
| 6th May 2021 10:00 am |
RNS |
Conference Attendance for May 2021 |
| 4th May 2021 7:00 am |
RNS |
Posting of Annual Report and Notice of AGM |
| 30th Apr 2021 7:00 am |
RNS |
Director Dealing |
| 23rd Apr 2021 7:00 am |
RNS |
Director Dealing |
| 15th Apr 2021 8:00 am |
RNS |
FY 2020 Investor Presentation |
| 14th Apr 2021 7:00 am |
RNS |
Final Results |
| 29th Mar 2021 12:45 pm |
RNS |
Exercise of Options and Total Voting Rights |
| 29th Mar 2021 12:00 pm |
RNS |
Destiny Pharma to Join Equity Development Webinar |
| 29th Mar 2021 11:06 am |
RNS |
Second Price Monitoring Extn |
| 29th Mar 2021 11:00 am |
RNS |
Price Monitoring Extension |
| 29th Mar 2021 10:15 am |
RNS |
Exercise of Options and Total Voting Rights |
| 29th Mar 2021 9:06 am |
RNS |
Second Price Monitoring Extn |
| 29th Mar 2021 9:00 am |
RNS |
Price Monitoring Extension |
| 29th Mar 2021 7:00 am |
RNS |
Destiny Pharma Reports Positive Phase 2b Results |
| 16th Mar 2021 7:00 am |
RNS |
Notice of Results |
| 15th Mar 2021 7:00 am |
RNS |
Destiny Pharma Announces Agreement with NIAID |
| 10th Mar 2021 2:15 pm |
RNS |
Exercise of Options and Total Voting Rights |
| 10th Mar 2021 7:00 am |
RNS |
Destiny Pharma CSO Joins UKRI COVID-19 Taskforce |
| 10th Feb 2021 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 10th Feb 2021 2:00 pm |
RNS |
Price Monitoring Extension |
| 3rd Feb 2021 7:00 am |
RNS |
Brazilian Patent Granted for XF-73 nasal gel |
| 2nd Feb 2021 7:05 am |
RNS |
Destiny Pharma to join panel discussion at LSX |
| 2nd Feb 2021 7:00 am |
RNS |
Destiny Pharma Appoints Professor Mark Wilcox |
| 21st Jan 2021 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 21st Jan 2021 4:35 pm |
RNS |
Price Monitoring Extension |
| 21st Jan 2021 4:31 pm |
RNS |
Grant of Share Options |
| 21st Jan 2021 8:28 am |
RNS |
Destiny Pharma Investor Presentation |
| 14th Jan 2021 11:05 am |
RNS |
Second Price Monitoring Extn |
| 14th Jan 2021 11:00 am |
RNS |
Price Monitoring Extension |
| 7th Jan 2021 11:05 am |
RNS |
Second Price Monitoring Extn |
| 7th Jan 2021 11:00 am |
RNS |
Price Monitoring Extension |
| 7th Jan 2021 7:00 am |
RNS |
Destiny Pharma: Directors Dealings |
| 6th Jan 2021 8:00 am |
RNS |
Destiny Pharma Appoints Stephanie Bewick as CBO |
| 5th Jan 2021 7:00 am |
RNS |
Phase 2b trial of XF-73 completes recruitment |
| 23rd Dec 2020 2:09 pm |
RNS |
Grant of share options |
